Jakob Dupont

Insider Reports History

Entity
Individual
Location
C/O Oncomed Pharmaceuticals, Inc., 800 Chesapeake Drive, Redwood City, CA
Signature
/s/ Jakob Dupont
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jakob Dupont:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Pyxis Oncology, Inc. Director Stock Option (Right to Buy) 392K $1.5M $3.83 Sep 22, 2023 Direct
Atara Biotherapeutics, Inc. EVP, Head of R&D Common Stock 291K $113K $0.39 Mar 2, 2023 Direct
Pyxis Oncology, Inc. Director Common Stock 38.7K $54.2K $1.40 Mar 26, 2024 Direct
Atara Biotherapeutics, Inc. EVP, Head of R&D Employee Stock Option (Right to Buy) 318K Mar 1, 2023 Direct
Bolt Biotherapeutics, Inc. Director Stock Option (Right to Buy) 17K Sep 3, 2024 Direct
Apexigen, Inc. Director Stock Option (right to buy) 0 Aug 23, 2023 Direct

Insider Reports Filed by Jakob Dupont

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BOLT Bolt Biotherapeutics, Inc. Sep 3, 2024 2 $0 4 Sep 6, 2024 Director
BOLT Bolt Biotherapeutics, Inc. Sep 3, 2024 0 $0 3 Sep 6, 2024 Director
PYXS Pyxis Oncology, Inc. Mar 26, 2024 1 $0 4 Mar 28, 2024 Director
PYXS Pyxis Oncology, Inc. Sep 22, 2023 1 $0 4 Sep 26, 2023 Director
APGN Apexigen, Inc. Aug 23, 2023 3 $0 4 Aug 25, 2023 Director
PYXS Pyxis Oncology, Inc. Aug 23, 2023 3 $0 4 Aug 25, 2023 Director
PYXS Pyxis Oncology, Inc. Aug 23, 2023 0 $0 3 Aug 25, 2023 Director
ATRA Atara Biotherapeutics, Inc. Mar 2, 2023 1 -$18.4K 4 Mar 6, 2023 EVP, Head of R&D
ATRA Atara Biotherapeutics, Inc. Mar 1, 2023 2 $0 4 Mar 3, 2023 EVP, Head of R&D
ATRA Atara Biotherapeutics, Inc. Nov 16, 2022 2 -$19.5K 4 Nov 18, 2022 EVP, Head of R&D
APGN Apexigen, Inc. Sep 29, 2022 1 $0 4 Oct 3, 2022 Director
ATRA Atara Biotherapeutics, Inc. Aug 16, 2022 1 -$20.8K 4 Aug 18, 2022 EVP, Head of R&D
APGN Apexigen, Inc. Jul 29, 2022 0 $0 3/A Aug 24, 2023 Director
ATRA Atara Biotherapeutics, Inc. May 17, 2022 1 -$20.6K 4 May 19, 2022 EVP, Head of R&D
ATRA Atara Biotherapeutics, Inc. Mar 1, 2022 3 -$21.9K 4 Mar 3, 2022 EVP, Head of R&D
ATRA Atara Biotherapeutics, Inc. Feb 10, 2022 3 -$32.1K 4 Feb 14, 2022 EVP, Head of R&D
ATRA Atara Biotherapeutics, Inc. Jan 3, 2022 3 -$32.2K 4 Jan 5, 2022 EVP, Head of R&D
ATRA Atara Biotherapeutics, Inc. Dec 1, 2021 3 -$41.8K 4 Dec 3, 2021 EVP, Head of R&D
ATRA Atara Biotherapeutics, Inc. Nov 16, 2021 1 -$37.6K 4 Nov 18, 2021 EVP, Head of R&D
ATRA Atara Biotherapeutics, Inc. Nov 2, 2021 3 -$34.2K 4 Nov 4, 2021 EVP, Head of R&D
ATRA Atara Biotherapeutics, Inc. Aug 17, 2021 1 -$27K 4 Aug 19, 2021 EVP, Head of R&D
ATRA Atara Biotherapeutics, Inc. May 18, 2021 1 -$75.4K 4 May 20, 2021 EVP, Head of R&D